Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ferguson Enterprises Inc. Common Stock (FERG) vs Novavax Inc (NVAX) Price & Performance

Ferguson Enterprises Inc. Common StockTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Ferguson Enterprises Inc. Common Stock vs Novavax Inc — how do they compare? Ferguson Enterprises Inc. Common Stock trades at $228.4 (market cap $43.13B), while Novavax Inc trades at $12.4 (market cap $2.08B). The key difference: Ferguson Enterprises Inc. Common Stock is far larger — about 20.7× Novavax Inc's market cap, and Ferguson Enterprises Inc. Common Stock pays a 1.6% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ferguson Enterprises Inc. Common Stock for 0 Days and Novavax Inc for 59 Days on average.

FERGNVAX
Market Cap
$43.13B$2.08B
Volume
1,358,6348,501,139
Sector
IndustrialsHealth
52-Week High
$267.71$12.82
52-Week Low
$214.26$6.22
Typical Hold Time
0 Days59 Days
Enterprise Value
$49.58B$1.66B
Dividend Yield
1.6%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ferguson Enterprises Inc. Common Stock

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $12.82, up 1.26% with a bullish technical outlook. The company reported strong revenue of $1.12B in 2025 and net income of $440.30M, marking a significant turnaround. Recent earnings beats and FDA approvals for updated COVID-19 vaccines support momentum. However, negative cash flow and high debt levels pose challenges.

The outlook is mixed: analyst consensus is 74% Buy with bullish technical signals, but profitability remains volatile. Key risks include cash burn and competitive pressure. Upside depends on successful Matrix-M platform adoption and partnership execution. Investors should weigh strong recent performance against fundamental weaknesses.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FERG
100% Buy0% Sell
Avg holding period · 0 Days
NVAX
28% Buy72% Sell
Avg holding period · 59 Days

About Ferguson Enterprises Inc. Common Stock

Ferguson Enterprises, Inc. distributes plumbing, HVAC, waterworks, and related building products to professional contractors, builders, and facility managers across North America, operating through branches, showrooms, and digital commerce.

Read more on FERG →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX →